Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: 000250)

Market Cap	2.92T
Revenue (ttm)	204.28B
Net Income (ttm)	-5.59B
Shares Out	22.76M
EPS (ttm)	-245.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	213,392
Open	129,600
Previous Close	130,300
Day's Range	129,500 - 135,300
52-Week Range	61,000 - 230,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 400
• Stock Exchange: KOSDAQ
• Ticker Symbol: 000250